Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin and Pingyangmycin Injection for Plantar Warts
NCT07197541Phase 4Active, not recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2025
- Primary completion
- Nov 2026
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bleomycin, pingyangmycin in plantar wart, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Oct 2025; status: active, not recruiting.
02
Drugs
bleomycinpingyangmycin
03
Conditions
plantar wart
Beyond the preview
Go deeper on NCT07197541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07197541.